• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Enovix Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

    2/23/23 7:51:31 AM ET
    $CNXA
    $CYRN
    $EBAY
    $ENVX
    Recreational Games/Products/Toys
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $CNXA alert in real time by email

    Gainers

    • Windtree Therapeutics, Inc. (NASDAQ:WINT) rose 24% to $0.31 in pre-market trading. Windtree Therapeutics shares jumped 47% on Wednesday after the company was granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."
    • ETAO International Co., Ltd. (NASDAQ:ETAO) shares rose 22.2% to $5.50 in pre-market trading after jumping 15% on Wednesday.
    • Satixfy Communications Ltd. (NASDAQ:SATX) rose 18.5% to $1.54 in pre-market trading after gaining over 6% on Wednesday. The company recently named Mr. Ido Gur as Chief Executive Officer.
    • Enovix Corporation (NASDAQ:ENVX) rose 17.3% to $9.71 in pre-market trading after the company posted better-than-expected quarterly sales.
    • Genprex, Inc. (NASDAQ:GNPX) shares rose 15.2% to $1.89 in pre-market trading.
    • Jounce Therapeutics, Inc. (NASDAQ:JNCE) rose 13.1% to $1.12 in pre-market trading. Redx Pharma and Jounce reported recommended business combination.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) rose 8.5% to $1.08 in pre-market trading.
    • NVIDIA Corporation (NASDAQ:NVDA) rose 8.4% to $224.92 in pre-market trading after the company reported better-than-expected Q4 results and issued strong Q1 guidance.
    • Remitly Global, Inc. (NASDAQ:RELY) rose 8.4% to $12.63 in pre-market trading following upbeat Q4 results.
    • Ouster, Inc. (NYSE:OUST) shares rose 7.5% to $1.29 in pre-market trading. Ouster is expected to report its financial results for the fourth quarter on March 23, 2023.

    Losers

    • Lucira Health, Inc. (NASDAQ:LHDX) shares fell 27.4% to $0.1649 in pre-market trading after the company said it has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
    • Cyren Ltd. (NASDAQ:CYRN) shares dropped 25% to $0.2860 in pre-market trading after the company reported Nasdaq delisting determination.
    • FOXO Technologies Inc. (NYSE:FOXO) fell 9.7% to $0.6250 in pre-market trading after gaining 33% on Wednesday.
    • Ocean Biomedical, Inc. (NASDAQ:OCEA) fell 8.5% to $4.40 in pre-market trading after surging 43% on Wednesday.
    • Lucid Group, Inc. (NASDAQ:LCID) fell 8.1% to $9.17 in pre-market trading after the company reported worse-than-expected Q4 revenue. The company issued 2023 production guidance of 10,000 to 14,000 vehicles.
    • Teladoc Health, Inc. (NASDAQ:TDOC) fell 7.5% to $27.22 in pre-market after the company issued weak guidance.
    • Unity Software Inc. (NYSE:U) fell 6.3% to $35.47 in pre-market trading after the company reported worse-than-expected Q4 EPS and issued weak guidance.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 6.1% to $0.1540 in pre-market trading after declining around 27% on Wednesday. Connexa Sports Technologies reported receipt of Nasdaq delisting notice.
    • Gold Fields Limited (NYSE:GFI) fell 5.2% to $9.15 in pre-market trading after reporting for the year ended 31 Dec. 2022.
    • eBay Inc. (NASDAQ:EBAY) shares fell 4.4% to $45.75 in pre-market trading. eBay posted upbeat earnings for its fourth quarter, but issued weak earnings forecast for the first quarter.

    Now Read This: Investor Optimism Improves Slightly Following Fed Minutes

    Get the next $CNXA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNXA
    $CYRN
    $EBAY
    $ENVX

    CompanyDatePrice TargetRatingAnalyst
    Lucid Group Inc.
    $LCID
    3/18/2026$17.00Buy
    Citigroup
    Enovix Corporation
    $ENVX
    3/12/2026$6.00Neutral
    BofA Securities
    Teladoc Health Inc.
    $TDOC
    3/10/2026$11.00Hold → Buy
    Deutsche Bank
    Lucid Group Inc.
    $LCID
    3/4/2026$10.00Underperform
    BofA Securities
    Unity Software Inc.
    $U
    3/3/2026$19.00Underperform → Neutral
    BofA Securities
    Teladoc Health Inc.
    $TDOC
    2/26/2026$7.00Neutral → Buy
    BofA Securities
    Enovix Corporation
    $ENVX
    2/26/2026$15.00 → $7.50Hold
    TD Cowen
    eBay Inc.
    $EBAY
    2/19/2026$88.00Sell → Neutral
    Goldman
    More analyst ratings

    $CNXA
    $CYRN
    $EBAY
    $ENVX
    SEC Filings

    View All

    SEC Form 8-K filed by FOXO Technologies Inc.

    8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    3/24/26 5:21:44 PM ET
    $FOXO
    Life Insurance
    Finance

    eBay Inc. filed SEC Form 8-K: Regulation FD Disclosure, Leadership Update, Financial Statements and Exhibits

    8-K - EBAY INC (0001065088) (Filer)

    3/24/26 4:06:09 PM ET
    $EBAY
    Real Estate

    Remitly Global Inc. filed SEC Form 8-K: Leadership Update

    8-K - Remitly Global, Inc. (0001782170) (Filer)

    3/20/26 4:07:18 PM ET
    $RELY
    Real Estate

    $CNXA
    $CYRN
    $EBAY
    $ENVX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on Lucid Group with a new price target

    Citigroup initiated coverage of Lucid Group with a rating of Buy and set a new price target of $17.00

    3/18/26 8:56:23 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    BofA Securities initiated coverage on Enovix with a new price target

    BofA Securities initiated coverage of Enovix with a rating of Neutral and set a new price target of $6.00

    3/12/26 8:51:29 AM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous

    Teladoc upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Teladoc from Hold to Buy and set a new price target of $11.00

    3/10/26 8:39:03 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $CNXA
    $CYRN
    $EBAY
    $ENVX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Stevens Mark A

    4 - NVIDIA CORP (0001045810) (Issuer)

    3/24/26 5:13:39 PM ET
    $NVDA
    Semiconductors
    Technology

    SEC Form 4 filed by Tewksbury Ted L Iii

    4 - Ouster, Inc. (0001816581) (Issuer)

    3/23/26 4:05:18 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Shah Aarti S.

    4 - NVIDIA CORP (0001045810) (Issuer)

    3/20/26 8:14:03 PM ET
    $NVDA
    Semiconductors
    Technology

    $CNXA
    $CYRN
    $EBAY
    $ENVX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NVIDIA and Emerald AI Join Leading Energy Companies to Pioneer Flexible AI Factories as Grid Assets

    HOUSTON, March 23, 2026 (GLOBE NEWSWIRE) -- CERAWeek 2026 -- NVIDIA and Emerald AI today announced that they are working with AES, Constellation, Invenergy, NextEra Energy, Nscale Energy & Power and Vistra to power and advance a new class of AI factories that connect to the grid faster, generate valuable AI tokens and intelligence, and operate as flexible energy assets that can support the grid. By bringing together technology, energy and infrastructure leaders, the collaboration demonstrates how companies across industries can convene to support AI innovation in the United States, while building a more reliable power system for Americans. These next-generation AI factories will harness

    3/23/26 7:00:00 AM ET
    $NVDA
    Semiconductors
    Technology

    Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting

    Research Collaborators Identify Biomarkers that May Predict Patient Response to Reqorsa® Gene TherapyREQORSA is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung CancerREQORSA Boosts Natural Killer (NK) Cell Antitumor Activity AUSTIN, Texas, March 18, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its research collaborators will present at the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting being held April 17-22, 2026 in San Diego, California. The collaborators

    3/18/26 7:00:00 AM ET
    $GNPX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lucid Leadership to Speak at Bank of America's 2026 Global Automotive Summit

    NEWARK, Calif., March 17, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ:LCID), maker of the world's most advanced software-defined vehicles and technologies, today announced Marc Winterhoff, Interim CEO, and Taoufiq Boussaid, CFO, will participate in a fireside chat at Bank of America's 2026 Global Automotive Summit on Tuesday, March 17. The session is scheduled for 2:10 pm EDT and will be webcast live on Lucid's investor relations website at https://ir.lucidmotors.com. A replay of the webcast will be available for 90 days following the live presentation.About Lucid GroupLucid

    3/17/26 9:00:00 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    $CNXA
    $CYRN
    $EBAY
    $ENVX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Boulet Virginia bought $136,175 worth of shares (6,500 units at $20.95), increasing direct ownership by 3% to 228,342 units (SEC Form 4)

    4 - Ouster, Inc. (0001816581) (Issuer)

    3/9/26 7:35:06 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    Director Paulus Kenneth H bought $69,400 worth of shares (10,000 units at $6.94) (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    11/17/25 4:05:05 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Chief Technology Officer Frichtl Mark bought $49,327 worth of shares (5,045 units at $9.78), increasing direct ownership by 0.99% to 513,121 units (SEC Form 4)

    4 - Ouster, Inc. (0001816581) (Issuer)

    12/16/24 7:49:49 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    $CNXA
    $CYRN
    $EBAY
    $ENVX
    Leadership Updates

    Live Leadership Updates

    View All

    eBay Canada Appoints eBay Veteran Ashley Lawrence as General Manager

    TORONTO, March 2, 2026 /CNW/ - eBay Canada today announced the appointment of Ashley Lawrence as General Manager of eBay's marketplace business in Canada. His joining comes at a moment of strong momentum for the business, as innovation, live commerce, and cross-border trade unlock new growth opportunities for Canadian buyers and sellers. Lawrence returns to eBay for his second tenure with the company, having previously held leadership roles from 2007-2021, where he served in leadership roles across Analytics, Finance, and Strategy as well as Finance Director of eBay Classifieds

    3/2/26 8:00:00 AM ET
    $EBAY
    Real Estate

    Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer

    SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly" or the "Company") today announced the appointment of Sebastian J. Gunningham as Chief Executive Officer ("CEO") and member of the Board of Directors (the "Board"), effective February 19, 2026. Mr. Gunningham succeeds Co-Founder Matt Oppenheimer, who decided to transition the role of CEO to a new leader after nearly 15 years of driving transformative growth that built Remitly into one of the world's leading networks for digital and physical money movement. Mr. Oppenheimer will continue to serve as Chairman of the Board. Sebastian Gunningham brings decades of global leadership and product innovation exp

    2/18/26 4:05:00 PM ET
    $RELY
    Real Estate

    Remitly Reports Fourth Quarter and Full Year 2025 Results Above Outlook

    Reported first full year of GAAP profitabilityRecord fourth quarter results: revenue of $442.2 million, net income of $41.2 million, and Adjusted EBITDA of $88.6 million SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY), a trusted provider of financial services that transcend borders, reported results for the fourth quarter and full year ended December 31, 2025. "We ended 2025 with very strong results, exceeding our guidance for both revenue and Adjusted EBITDA," said Matt Oppenheimer, co-founder and Chief Executive Officer, Remitly. "These exceptional results and the strategic accomplishments realized in 2025 create the right moment to accelerate execution wi

    2/18/26 4:04:00 PM ET
    $RELY
    Real Estate

    $CNXA
    $CYRN
    $EBAY
    $ENVX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Windtree Therapeutics Inc.

    SC 13G/A - WINDTREE THERAPEUTICS INC /DE/ (0000946486) (Subject)

    11/14/24 7:15:44 PM ET
    $WINT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Windtree Therapeutics Inc.

    SC 13G - WINDTREE THERAPEUTICS INC /DE/ (0000946486) (Subject)

    11/14/24 3:40:27 PM ET
    $WINT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by eBay Inc.

    SC 13G - EBAY INC (0001065088) (Subject)

    11/14/24 12:15:25 PM ET
    $EBAY
    Real Estate

    $CNXA
    $CYRN
    $EBAY
    $ENVX
    Financials

    Live finance-specific insights

    View All

    Ouster Announces Results for Fourth Quarter and Full Year 2025

    Record revenue and gross margins, achieving 12th straight quarter of product revenue growth Record quarterly lidar shipments of 8,100 units; 2025 shipments exceed 25,000 Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, announced today financial results for the three months and year ended December 31, 2025. "2025 was a year of exceptional execution for Ouster. Our strong revenue growth and gross margin performance are a testament to our disciplined focus as we pioneer the technologies driving the secular shift towards Physical AI, delivering record results," said Ouster CEO Angus Pacala. "As we look forward, the strength of our

    3/2/26 4:10:00 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    NVIDIA Announces Financial Results for Fourth Quarter and Fiscal 2026

    Record quarterly revenue of $68.1 billion, up 20% from Q3 and up 73% from a year agoRecord quarterly Data Center revenue of $62.3 billion, up 22% from Q3 and up 75% from a year agoRecord full-year revenue of $215.9 billion, up 65% SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported record revenue for the fourth quarter ended January 25, 2026, of $68.1 billion, up 20% from the previous quarter and up 73% from a year ago. For fiscal 2026, revenue was $215.9 billion, up 65% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 75.0% and 75.2%, respectively. For fiscal 2026, GAAP and non-GAAP gross margins were 71.1% and

    2/25/26 4:31:17 PM ET
    $NVDA
    Semiconductors
    Technology

    Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

    NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 ("Fourth Quarter 2025") and full year ended December 31, 2025 ("Full Year 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 ("Fourth Quarter 2024") and full year ended December 31, 2024 ("Full Year 2024"). Highlights Fourth Quarter 2025 revenue of $642.3 million, flat year-over-year, and Full Year 2025 revenue of $2,530.0 million, down 2% year-over-yearFourth Quarter 2025 net loss of $25.1 million, or $0.14 per share, and Full Year 2

    2/25/26 4:05:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care